Prevalence and Hormonal Profiling of Secondary Amenorrheic Patients Presenting to a Fertility Clinic – An Observational Study

    October 2025 in “ Česká gynekologie ”
    Nayab Iqbal, Muhammad Ashfaq, Qasim Raza Khan, Syed Mobasher Ali Abid, Muhammad Junaid Hassan Sharif, Yasser MSA Alkahraman
    Image of study
    TLDR Hyperprolactinemia is the most common cause of secondary amenorrhea, followed by drug use.
    The study conducted on 126 patients with secondary amenorrhea in Abbottabad fertility clinics found that hyperprolactinemia is the most common cause, affecting 31.7% of patients, followed by drug-induced amenorrhea at 14.3%. Among those with drug-induced amenorrhea, 38.9% used oral contraceptives, 27.8% used omeprazole, and 33.3% used other drugs. Common symptoms included headache (79.4%), fatigue (78.6%), and hair loss (65.9%). The findings highlight the importance of considering hyperprolactinemia and drug use in the clinical management of secondary amenorrhea.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 7 results

      community how about progesterone cream?

      in Research/Science  23 upvotes 1 year ago
      Progesterone cream might help with hair loss by inhibiting DHT production and suppressing prolactin, which can increase DHT. Some dermatologists have used progesterone for hair loss treatment, and it has been effective, sometimes combined with minoxidil, finasteride, and hydrocortisone.

      community hmi115 is coming. Prepare yourselves for what's coming

      in Technology  106 upvotes 2 years ago
      The conversation discusses HMI-115, a potential cure for hair loss. Users share mixed opinions, with some expressing skepticism and others sharing anecdotal evidence of its effectiveness, including photos of significant hair regrowth from a trial participant.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 2 years ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  36 upvotes 6 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

    Similar Research

    5 / 750 results